VDI
CVS icon

Vaughan David Investments’s CVS Health CVS Stock Holding History

Vaughan David Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.2M Buy
427,349
+5,008
+1% +$447K 0.88% 50
2026
Q1 		$30.3M Buy
422,341
+6,890
+2% +$531K 0.64% 82
2025
Q4 		$33M Buy
415,451
+3,080
+0.7% +$243K 0.72% 73
2025
Q3 		$31.1M Buy
412,371
+11,245
+3% +$771K 0.67% 78
2025
Q2 		$27.7M Buy
401,126
+4,748
+1% +$311K 0.62% 82
2025
Q1 		$26.9M Buy
396,378
+23,624
+6% +$1.41M 0.63% 82
2024
Q4 		$16.7M Sell
372,754
-33,059
-8% -$1.85M 0.4% 86
2024
Q3 		$25.5M Buy
405,813
+7,327
+2% +$427K 0.59% 83
2024
Q2 		$23.5M Buy
398,486
+19,188
+5% +$1.2M 0.6% 83
2024
Q1 		$30.3M Buy
379,298
+6,675
+2% +$510K 0.75% 78
2023
Q4 		$29.4M Sell
372,623
-9,699
-3% -$690K 0.81% 74
2023
Q3 		$26.7M Buy
382,322
+12,720
+3% +$901K 0.81% 73
2023
Q2 		$25.6M Buy
369,602
+8,830
+2% +$628K 0.75% 74
2023
Q1 		$26.8M Buy
360,772
+4,150
+1% +$348K 0.81% 71
2022
Q4 		$33.2M Buy
356,622
+5,385
+2% +$520K 0.99% 53
2022
Q3 		$33.5M Buy
351,237
+4,275
+1% +$423K 1.12% 35
2022
Q2 		$32.1M Buy
346,962
+7,970
+2% +$778K 1.03% 51
2022
Q1 		$34.3M Buy
338,992
+2,562
+0.8% +$269K 1.01% 49
2021
Q4 		$34.7M Buy
336,430
+4,369
+1% +$404K 1.01% 47
2021
Q3 		$28.2M Buy
332,061
+6,805
+2% +$570K 0.9% 65
2021
Q2 		$27.1M Buy
325,256
+9,705
+3% +$795K 0.85% 71
2021
Q1 		$23.7M Buy
315,551
+14,890
+5% +$1.08M 0.75% 74
2020
Q4 		$20.5M Buy
300,661
+7,408
+3% +$482K 0.7% 73
2020
Q3 		$17.1M Buy
293,253
+1,320
+0.5% +$82.1K 0.66% 71
2020
Q2 		$19M Buy
291,933
+7,585
+3% +$478K 0.78% 69
2020
Q1 		$16.9M Sell
284,348
-4,473
-2% -$299K 0.78% 64
2019
Q4 		$21.5M Buy
288,821
+5,645
+2% +$396K 0.79% 68
2019
Q3 		$17.9M Buy
283,176
+11,046
+4% +$655K 0.68% 76
2019
Q2 		$14.8M Buy
272,130
+18,878
+7% +$1.02M 0.59% 77
2019
Q1 		$13.7M Buy
253,252
+20,285
+9% +$1.25M 0.58% 80
2018
Q4 		$15.3M Sell
232,967
-14,043
-6% -$1.05M 0.71% 72
2018
Q3 		$19.4M Buy
247,010
+5,430
+2% +$388K 0.82% 66
2018
Q2 		$15.5M Buy
241,580
+10,128
+4% +$667K 0.72% 77
2018
Q1 		$14.4M Buy
231,452
+3,003
+1% +$215K 0.68% 76
2017
Q4 		$16.6M Buy
228,449
+10,569
+5% +$768K 0.77% 75
2017
Q3 		$17.7M Buy
217,880
+900
+0.4% +$71.2K 0.87% 69
2017
Q2 		$17.5M Sell
216,980
-18,230
-8% -$1.44M 0.88% 70
2017
Q1 		$18.5M Buy
235,210
+45,055
+24% +$3.6M 0.96% 66
2016
Q4 		$15M Buy
190,155
+2,522
+1% +$204K 0.8% 78
2016
Q3 		$16.7M Buy
187,633
+5,385
+3% +$508K 0.91% 70
2016
Q2 		$17.4M Buy
182,248
+6,130
+3% +$611K 0.96% 65
2016
Q1 		$18.3M Buy
176,118
+5,668
+3% +$551K 1.04% 57
2015
Q4 		$16.7M Buy
170,450
+15,198
+10% +$1.49M 1% 61
2015
Q3 		$15M Buy
155,252
+27,250
+21% +$2.86M 0.95% 66
2015
Q2 		$13.4M Buy
128,002
+121,029
+1,736% +$12.4M 0.79% 76
2015
Q1 		$720K Buy
6,973
+168
+2% +$17K 0.04% 104
2014
Q4 		$655K Hold
6,805
– – 0.04% 109
2014
Q3 		$542K Sell
6,805
-159
-2% -$12.5K 0.03% 108
2014
Q2 		$525K Buy
6,964
+159
+2% +$12K 0.03% 112
2014
Q1 		$509K Sell
6,805
-50
-0.7% -$3.53K 0.03% 112
2013
Q4 		$491K Sell
6,855
-165
-2% -$10.6K 0.03% 109
2013
Q3 		$398K Hold
7,020
– – 0.03% 117
2013
Q2 		$401K Buy
+7,020
New +$407K 0.03% 112

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vaughan David Investments's CVS Position: Q2 2026 in Review

Vaughan David Investments increased its CVS Health (CVS) stake by 1.2% in Q2 2026, buying an estimated $447K and bringing the position to 427,349 shares worth $44.2M. The position accounts for 0.88% of the portfolio, ranked #50.

Vaughan David Investments first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Vaughan David Investments held 427,349 shares of CVS Health worth $44.2M as of Q2 2026.
  • Vaughan David Investments bought 5,008 CVS Health shares in Q2 2026, an estimated $447K.
  • CVS Health made up 0.88% of Vaughan David Investments's portfolio in Q2 2026, its #50 holding.
  • Vaughan David Investments first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Vaughan David Investments's 13F filing for Q2 2026, filed 11 Aug 2026.